Stay updated on Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a website software/version change rather than a change to the study information.
    Difference
    0.1%
    Check dated 2026-04-25T06:03:02.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:49:46.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Added revision: v3.5.0 and removed revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-20T04:26:15.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.3 instead of v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-05T19:43:39.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.1 to v3.4.2 with no visible changes to study details or page layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T02:06:11.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    A minor revision label changed from v3.4.0 to v3.4.1; no observable changes to core study content or page structure. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T23:54:06.000Z thumbnail image

Stay in the know with updates to Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Concurrent VRP-HER2 & Pembrolizumab in Breast Cancer Clinical Trial page.